.jpg)
.png)
All
Epidemiology The ever- increasing population of patients living after organ transplantation has added an important dimension to the specific management needs of these patients. One major area in this regard pertains to the effects of post-transplant immunosuppressive drugs on lipids and... more
.btn-about { margin: 10px; } .v-center { display: flex; align-items: flex-start; justify-content: center; flex-grow: 1; width: 390px; padding:10px } .flex-row { display: flex; flex-wrap: wrap; justify-content: center; } .well { width: 100... more
The National Lipid Association (NLA) and the American Society for Preventive Cardiology (ASPC) have released a joint clinical perspective in the Journal of Clinical Lipidology (JCL) and the American Journal of Preventive Cardiology (AJPC) strongly encouraging clinicians to recognize the... more
.color-blue{ color: #23527c; } Case Presentation: G.S. is a 60-year-old male referred for cholesterol treatment complicated by background liver disease. He has a history of schizophrenia and chronic hepatitis C virus (HCV) diagnosed in 2016. He is asymptomatic and denied having... more
Listen to Moderator Ralph La Forge, MSc, CLS, FNLA and Speaker Harold E. Bays, MD, FNLA as they discuss the application of a case study to the NLA’s recently published Recommendations.
The National Lipid Association (NLA) today announced the publication of a new meta-analysis evaluating the impact of low-density lipoprotein cholesterol (LDL-C) lowering on major adverse cardiovascular events (MACE) in primary prevention populations. The study synthesizes data from randomized... more
Risk assessment tools and lifestyle surveys can play a major role in screening patients for risk of atherosclerotic cardiovascular disease (ASCVD), allowing for early targeted interventions. It is known that race can greatly impact risk, yet it isn’t incorporated in all risk calculators. Similarly... more